Transvaginal mesh lawsuits included in the consolidated Gynecare litigation have been subjected to an order in which Johnson & Johnson subsidiary Ethicon was required to produce all communications it had with the U.S. Food & Drug Administration.
A troubling number of reports have surfaced linking transvaginal mesh to serious side effects including erosion of the mesh into the vaginal tissue, infection, bleeding, pain, and recurrence of the urinary problems the devices were implanted to treat in the...
The plaintiff, from Tennessee, was reportedly implanted with a Boston Scientific Obtryx Tansobturator Mid-Urethral Sling System, and subsequently suffered debilitating personal injuries.
Johnson & Johnson continued to sell its controversial Gynecare Prolift transvaginal mesh patch for nine months after the FDA ordered it to stop, according to court records.
A judge has lifted the discovery stay in the federal transvaginal mesh litigation, as scores of new cases continue to be filed on behalf of women in courthouses around the country.
Pharmaceutical giant Johnson & Johnson is facing nearly 300 lawsuits over a transvaginal mesh device that was approved by the FDA based on a similar product that was recalled from the market nearly a decade ago over safety concerns.